JP Morgan Upgrades CME Group to Overweight, Announces $367 Price Target
JP Morgan analyst Kenneth Worthington upgrades CME Group (NASDAQ:CME) from Underweight to Overweight and announces $367 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga